FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 137 filers reported holding FLEXION THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,517,000 | +1.6% | 478,109 | -8.3% | 0.10% | -27.1% |
| Q3 2020 | $5,430,000 | -27.7% | 521,582 | -8.7% | 0.14% | -32.4% |
| Q2 2020 | $7,511,000 | +61.7% | 571,188 | -3.2% | 0.21% | +27.5% |
| Q1 2020 | $4,646,000 | -61.9% | 590,298 | +0.3% | 0.17% | -46.1% |
| Q4 2019 | $12,179,000 | +13.7% | 588,368 | -24.7% | 0.31% | +6.5% |
| Q3 2019 | $10,709,000 | +15.2% | 781,377 | +3.4% | 0.29% | +27.1% |
| Q2 2019 | $9,296,000 | -1.7% | 755,774 | -0.2% | 0.23% | -3.4% |
| Q1 2019 | $9,455,000 | +8.0% | 757,585 | -2.0% | 0.24% | -4.0% |
| Q4 2018 | $8,751,000 | -39.9% | 773,045 | -0.6% | 0.25% | -28.4% |
| Q3 2018 | $14,552,000 | -15.5% | 777,775 | +16.8% | 0.34% | -19.8% |
| Q2 2018 | $17,220,000 | +21.5% | 666,160 | +5.4% | 0.43% | +24.3% |
| Q1 2018 | $14,169,000 | -14.6% | 632,270 | -4.6% | 0.35% | -11.3% |
| Q4 2017 | $16,598,000 | +15.3% | 662,875 | +11.4% | 0.39% | +13.0% |
| Q3 2017 | $14,392,000 | +0.4% | 595,211 | -16.1% | 0.34% | -3.6% |
| Q2 2017 | $14,341,000 | -25.4% | 709,263 | -0.5% | 0.36% | -26.8% |
| Q1 2017 | $19,220,000 | +37.1% | 712,631 | -3.3% | 0.49% | +34.3% |
| Q4 2016 | $14,016,000 | -0.8% | 736,887 | +1.9% | 0.36% | -1.1% |
| Q3 2016 | $14,126,000 | – | 722,905 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|